Ticker

Vinci SA (VCISY) Q4 2025 Earnings Call Transcript

Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive's minimally invasive technologies Achievement reflects the dedication of surgeons and care teams worldwide to improving patient outcomes through use of Intuitive's minimally invasive technologies

ISRG's da Vinci 5 begins international rollout, but pricing sensitivity, budgets, and reimbursement hurdles could slow adoption outside the United States.

Vinci SA (OTCMKTS:VCISY - Get Free Report) gapped down prior to trading on Friday. The stock had previously closed at $36.07, but opened at $35.22. Vinci shares last traded at $35.25, with a volume of 20,865 shares traded. Wall Street Analyst Weigh In Separately, Zacks Research downgraded shares of Vinci from a "hold" rating

ISRG is positioning da Vinci 5 as a TAM expander, targeting cardiac surgery long term while advancing near-term regulatory steps in general surgery.